Literature DB >> 23928200

1H magnetic resonance spectroscopy in multiple sclerosis and related disorders.

Alex Rovira1, Juli Alonso.   

Abstract

Proton magnetic resonance spectroscopy ((1)H-MRS) is an unconventional technique that allows noninvasive characterization of metabolic abnormalities in the central nervous system. (1)H-MRS provides important insights into the chemical-pathologic changes that occur in patients with multiple sclerosis (MS). In this review article we present the main brain and spinal cord (1)H-MRS features in MS, their diagnostic value in differentiating pseudotumoral demyelinating lesions from primary brain tumors, and their relationship with clinical variables. Last, some data related to the use of (1)H-MRS in therapeutic trials is presented.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain; Diagnosis; Magnetic resonance spectroscopy; Multiple sclerosis; Spinal cord

Mesh:

Substances:

Year:  2013        PMID: 23928200     DOI: 10.1016/j.nic.2013.03.005

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  11 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 2.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

3.  Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.

Authors:  Ivan I Kirov; Shu Liu; Assaf Tal; William E Wu; Matthew S Davitz; James S Babb; Henry Rusinek; Joseph Herbert; Oded Gonen
Journal:  Hum Brain Mapp       Date:  2017-05-19       Impact factor: 5.038

4.  Cardiac autonomic function in patients with early multiple sclerosis.

Authors:  Richard Imrich; Miroslav Vlcek; Adela Penesova; Zofia Radikova; Andrea Havranova; Monika Sivakova; Pavel Siarnik; Branislav Kollar; Tomas Sokolov; Peter Turcani; Eva Heckova; Gilbert Hangel; Bernhard Strasser; Wolfgang Bogner
Journal:  Clin Auton Res       Date:  2021-03-04       Impact factor: 4.435

5.  Whole-Brain Metabolic Abnormalities Are Associated With Mobility in Older Adults With Multiple Sclerosis.

Authors:  Christina Mueller; Jessica F Baird; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2022-02-14       Impact factor: 3.919

6.  Recent imaging advances in neurology.

Authors:  Lorenzo Rocchi; Flavia Niccolini; Marios Politis
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

Review 7.  Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.

Authors:  Ana C Londoño; Carlos A Mora
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-11-20

8.  Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.

Authors:  Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher
Journal:  NMR Biomed       Date:  2020-04-29       Impact factor: 4.044

9.  Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.

Authors:  Mehmet Fatih Yetkin; Meral Mirza; Halil Dönmez
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

10.  2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis.

Authors:  Scott Quadrelli; Karen Ribbons; Jameen Arm; Oun Al-Iedani; Jeannette Lechner-Scott; Rodney Lea; Saadallah Ramadan
Journal:  Ther Adv Neurol Disord       Date:  2019-10-19       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.